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Abstract: Population growth combined with increasingly limited resources of arable land and fresh
water has resulted in a need for alternative protein sources. Macroalgae (seaweed) and microalgae
are examples of under-exploited “crops”. Algae do not compete with traditional food crops for space
and resources. This review details the characteristics of commonly consumed algae, as well as their
potential for use as a protein source based on their protein quality, amino acid composition, and
digestibility. Protein extraction methods applied to algae to date, including enzymatic hydrolysis,
physical processes, and chemical extraction and novel methods such as ultrasound-assisted extraction,
pulsed electric field, and microwave-assisted extraction are discussed. Moreover, existing protein
enrichment methods used in the dairy industry and the potential of these methods to generate high
value ingredients from algae, such as bioactive peptides and functional ingredients are discussed.
Applications of algae in human nutrition, animal feed, and aquaculture are examined.
Keywords: seaweed; microalgae; peptides; phycobiliproteins; biorefinery; bioavailability; extraction
methods; legislation
1. Introduction
The global population is expected to increase by over a third (2.3 billion people) by 2050,
requiring an estimated 70% increase in food production [1]. A combination of improved agricultural
food production methods and an increase of average per capita income have led to a decrease in
global hunger over the last half-century, despite a doubling of the world’s population [1]. However,
worldwide food production is now facing a greater challenge than ever before. Previously utilised
methods of intensifying agriculture will soon no longer be an option due to the high impact trade-offs
they have on the environment, including fragmenting natural habitats and threatening biodiversity,
production of greenhouse gases from land clearing, fertilisers and animal livestock production, and
nutrient run-off from fertiliser damaging marine, freshwater and terrestrial ecosystems [2]. In particular,
protein is one of the main nutrients that will be in short supply in the future. Alternative protein
sources and production methods are required to fulfil the demand of consumers and to meet predicted
global protein requirements.
Seaweed and microalgae are considered a viable source of protein. Some species of seaweed
and microalgae are known to contain protein levels similar to those of traditional protein sources,
such as meat, egg, soybean, and milk [3,4]. Algae use for protein production has several
benefits over traditional high-protein crop use in terms of productivity and nutritional value.
Seaweed and microalgae have higher protein yield per unit area (2.5–7.5 tons/Ha/year and
4–15 tons/Ha/year, respectively) compared to terrestrial crops, such as soybean, pulse legumes, and
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wheat (0.6–1.2 tons/Ha/year, 1–2 tons/Ha/year, and 1.1 tons/Ha/year, respectively) [5]. Terrestrial
agriculture already requires approximately 75% of the total global freshwater with animal protein
in particular requiring 100 times more water than if the equivalent amount of protein was produced
from plant sources [6,7]. Marine algae do not require freshwater or arable land to grow, maximising
resources that can be used for additional food production or other cash crops [5]. Furthermore, due to
their harsh environment and phototropic life, algae are often exposed to high oxidative and free-radical
stresses [8]. This has led to the evolution of natural protective systems, such as the production
of pigments (e.g., carotenes, chlorophylls, and phycobiliproteins) and polyphenols (e.g., catechins,
flavonols, and phlorotannins), which can impart health benefits to the consumer when eaten [9,10].
However, widespread use of seaweed and microalgae is limited by a number of factors including;
harvesting access and rights, seasonality and geographical location of algae, as well as the availability
of scalable production methods for protein isolation from algae. Current processes of algal protein
isolation are time-consuming and economically unviable [11]. The objective of this paper is therefore
to discuss the value of algal proteins as a source of human nutrition, functional foods and animal feed,
as well as describe current extraction methods and novel processing technologies that are used in dairy
processing which may be employed to make algae a viable source of protein ingredients.
1.1. Characteristics of Seaweed
Algae are a diverse group of species which can be broadly described as oxygen-producing,
photosynthetic, unicellular or multicellular organisms excluding embryophyte terrestrial plants and
lichens [12]. Macroalgae can be divided into three main taxonomic groups based on their pigmentation;
Phaeophyta (brown algae), Chlorophyta (green algae), and Rhodophyta (red algae) [13].
According the Food Balance sheets published by the Food and Agriculture Organisation of the
United Nations (FAO), the Republic of Korea is the greatest consumer of seaweed (22.41 kg/capita/year
in 2013), followed by China and Japan [14]. Production of farmed seaweed has more than doubled
worldwide since 2000, with particular expansion seen in Indonesia due to their vast areas of shallow
sunlight coasts suitable for culture sites [15]. The culture of Japanese kelp, Laminaria japonica, has
traditionally been the most extensively farmed cold-water species. This was surpassed by the tropical
Eucheuma seaweeds (Kappaphycus alvarezii and Eucheuma spp.) in 2010. The other most commonly
farmed seaweed species are Gracilaria spp., Undaria sp., and Porphyra spp. [15].
Brown algae are distinguished by the presence of the pigment fucoxanthin, which is responsible
for the distinctive olive-brown colour that lends this group its name [13]. Brown algae are also
unique among algae as they are only found in multicellular form [16]. There are approximately
1500–2000 species of brown algae worldwide [17]. Some species, such as Macrocystis pyrifera
(giant kelp), play an important role in the ecosystem, growing up to 20 m and forming underwater
kelp forests [18]. There are also many other species that have been exploited for human consumption,
including Undaria pinnatifida (wakame), Hizikia fusiformis (hijiki), and Laminaria japonica (kombu) [19].
Several types of brown algae are used for animal feed, including Laminaria digitata (oarweed),
Ascophyllum nodosum (rockweed) and Fucus vesiculosus (bladder wrack) [3].
Green algae are a diverse group of approximately 8000 species, consisting of the divisions
Chlorophyta and Charophyta [20]. Chlorophyta are a large group of unicellular and multicellular
algae, while charophyta are a smaller group of exclusively freshwater, multicellular green algae from
which it is believed that Embryophyta (terrestrial plants) evolved from [21]. Green algae obtain
their pigmentation from chlorophyll a and b, as well as other pigments including β-carotene and
xanthophylls [13]. The most commonly consumed species of green algae are Ulva spp. including
U. lactuca (sea lettuce), U. intestinalis, and U. compressa.
Red algae are a large group of mostly multicellular macroalgae with approximately
6000 species [13]. Red algae are characterised by the presence of phycobilins, which are responsible
for their red colour [13]. Species of Irish moss, such as Chondrus crispus and Mastocarpus stellatus, are
exploited for their production of carrageenan [22]. Other species of red algae, including Porphyra tenera
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(nori) and Palmaria palmata (dulse), are among the highest consumed species of seaweed in Asia, as well
as Western countries, due to their high protein content and their delectable flavour [23]. In particular,
Porphyra tenera is used in the production of sushi.
1.2. Characteristics of Microalgae
Microalgae are unicellular, microscopic organisms that are also considered as a viable alternative
protein source. The most abundant microalgal divisions are Bacillariophyta (diatoms), Chlorophyta
(green algae), Chrysophyta (golden algae), and Cyanophyta (blue-green algae). Microalgae are a
hugely diverse group containing approximately 200,000 species [24]. Several of these species are
currently exploited for a variety of biotechnological purposes, including cosmeceuticals, animal feed,
fatty acids, alginates, wastewater treatment, and biofuel [9,25,26]. Furthermore, Arthrospira platensis
(Spirulina), and Chlorella vulgaris (Chlorella) are also sold as functional foods due to their high vitamin
and mineral content and as they are generally regarded as safe (GRAS) by the European Food Safety
Authority (EFSA) [25]. Despite the relatively low quantity of microalgae produced annually compared
to that of seaweed (5000 tonnes dry matter per year versus 7.5 × 106 tonnes dry matter per year,
respectively), whole microalgal biomass and added-value compounds are economically valuable,
representing a global turnover of about US $1.25× 109 per year, compared to annual seaweed turnover
of US $6 × 109 [9].
Arthrospira platensis is a filamentous Cyanobacterium that has among the highest recorded protein
content of any whole food [27]. Arthrospira sp. was originally referred to as Spirulina sp. until
a re-examination showed that they are actually a distinct genus [9]. However, due to its widely
publicised use as a food and dietary supplement, the term Spirulina is often used interchangeably
with Arthrospira.
Chlorella spp. are spherical members of the phylum Chlorophyta (green algae) that have also seen
increased popularity as a food supplement in recent times. Chlorella vulgaris is the most commonly
exploited industry species due to its high protein content (51%–58% dry weight; dw) and favourable
essential amino acid composition [28]. Chlorella also contains many other beneficial nutrients, including
β-1,3-glucan, vitamins (B-complex and ascorbic acid), minerals (potassium, sodium, magnesium, iron,
and calcium), β-carotene, chlorophyll, and Chlorella growth factor (CGF) [29].
2. Protein Quality
2.1. Amino Acid Composition
The quality of proteins can vary dramatically, depending on digestibility and the availability of
essential amino acids [30]. Animal sources of protein are generally considered as complete proteins, as
they are a rich source of essential amino acids (EAAs) which the human body is unable to biosynthesise.
Alternatively, plant proteins are often considered an incomplete protein source as they commonly lack
one or more of the essential amino acids, including histidine, isoleucine, leucine, lysine, methionine,
phenylalanine, threonine, tryptophan, and valine [31]. However, the lacking essential amino acid(s) in
plant-based proteins can differ, meaning that an individual should be able to obtain a sufficient quantity
of all essential amino acids if they consume a varied diet of plant proteins from fruit, vegetables, grains,
and legumes [32]. Plant-based proteins are also typically harder to digest than animal proteins, due to
their high concentration of insoluble polysaccharides. Despite this, there are increasing concerns about
the high levels of saturated fats and cholesterol found in foods of animal origin, which are linked to the
development of cardiovascular disease and diabetes. This has led to nutritionists and organisations,
such as the FAO, recommending a more varied diet rich in plant-based proteins [33].
Algae are generally regarded as a viable protein source, with EAA composition meeting FAO
requirements and they are often on par with other protein sources, such as soybean and egg [3,33].
The lack of widespread consumption of marine algae has led to a shortage of in vivo research regarding
the ileal digestion of algae, thus limiting the comparison of algal protein quality between different
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algae species, as well as with other protein sources [34]. Nevertheless, tryptophan and lysine are often
limiting amino acids in most algae species [35–37]. Furthermore, leucine and isoleucine are commonly
found in low concentrations in red species of algae, while methionine, cysteine, and lysine are often
limiting in brown algae species [35,38]. Cysteine typically occurs at low levels in many seaweed
species, and is often not detectable [39]. Aspartic acid and glutamic acid constitute a relatively large
proportion of the total amino acids in many seaweed species, largely contributing to the distinctive
‘umami’ taste associated with seaweed [40]. For example, these two amino acids have been reported to
represent 22%–44% of total amino acids in Fucus sp. and 26%–32% in Ulva sp. [3].
2.2. Algal Protein Digestibility
Bioavailability can be described as the fraction of ingested food components that is available at
the target site of action for utilisation in various physiological functions [41]. Bioavailability entails
the entire process following food element consumption, including digestibility and solubility of the
food element in the gastrointestinal tract, absorption/assimilation of the food element across the
intestinal epithelial cells and into the circulatory system, and finally, incorporation into the target
site of utilisation (Figure 1) [42]. Studies examining the bioavailability of food elements are therefore
required to incorporate in vivo experiments. One in vivo study evaluated the bioavailability of P. tenera
and U. pinnatifida in Wistar rats, which reported that the fibre in seaweed had a negative impact on
protein intake digestibility and food efficiency [43]. Similarly, L. japonica was also reported to decrease
protein digestibility in rats, although interestingly, digestibility ended up being comparable with the
control diet after 3 weeks as the rats appeared to adapt to the high fibre diet [44]. It is thought that
phlorotannins and high polysaccharide content are the main factors which negatively impact the
digestibility of algal proteins [45,46].
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Bioavailability can be further divided into two different stages; bioaccessibility and bioactivity. 
Bioaccessibility involves examining the fraction of particular components that are released from the 
Figure 1. Schematic representation of digestion and methods that may be used to determine
bioavailability, bio-accessibility and bioactivity of proteins and other foods. Adapted from
Carbonell-Capella et al. [47]. TIM: TNOASR’s intestinal model; TNOASR: The Netherlands
Organization for Applied Scientific Research.
Bioavailability can be further divided into two different stages; bioaccessibility and bioactivity.
Bioaccessibility involves examining the fraction of particular components that are released from the
whole food matrix within the gastrointestinal tract in order to identify elements that are accessible
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for further absorption [48]. Bioactivity refers to the assimilation of a food elemen14 t across intestinal
cells, transport of the element to the target site, interaction of the element with the target site, any
necessary biotransformation of the food element, and the physiological response created as a result
of incorporation of the element with the target site (Figure 1) [49]. There are many factors affecting
digestibility which can make in vitro studies difficult, including the macronutrient composition, enzyme
specificity, anti-nutritional factors, fibre, and varying absorptive capacities at different stages within the
gastrointestinal tract [30]. Nevertheless, in vitro studies serve as a useful preliminary screening tool to
identify promising food matrices, growing conditions, and processing methods [48,50,51].
Methods for assessing in vitro digestibility are typically divided into four categories, including
solubility, dialysability, gastrointestinal chambers, and cell models [48]. Only small, soluble molecules
can be absorbed in the small intestine, which can be evaluated by methods such as atomic absorption
spectrophotometry, mass spectrometry, or high-performance liquid chromatography [48]. Dialysability
is a direct measure of a food components ability to cross a membrane, although dialysability assays
have typically been carried out on micronutrients, including iron, zinc, magnesium and calcium [52].
Bioaccessibility in vitro studies are typically accomplished using either static or dynamic
measuring systems. Static systems are the more basic of the two, measuring the release of free
amino acids from dietary proteins following hydrolysis from gastrointestinal enzymes under discrete
pH and temperature [49]. Static systems have the advantage of being easily implemented, low cost,
and high throughput, but have the disadvantage of being unrealistic for normal gastrointestinal
physiological processes. Alternatively, dynamic systems use computer systems to tightly regulate pH,
temperature, enzyme addition, mixing and residence times within chambers in order to more closely
mimic gastrointestinal digestion [48]. These systems model gastric physiology more accurately, but
have the drawbacks of being costly and low throughput, limiting their routine use.
The Netherlands Organization for Applied Scientific Research (TNOASR) has developed two
similar dynamic gastrointestinal models, called TNOASR’s intestinal model (TIM-1 and TIM-2) [48].
The TIM-1 system contains several compartments used to mimic the effect of the stomach and small
intestine (including duodenum, jejunum, and ileum) [53]. TIM-2 focuses on the large intestine, serving
as a tool to study the effect of microbial fermentation and nutrient absorption in the colon [54].
In both models, aliquots can be taken from any chamber at any given time [48]. Additional in vitro
gastrointestinal models have also been described to study digestion and microbiota colonisation [55–58].
However, one such issue that plagues digestibility studies is the lack of consistency occurring in
differing methodologies, making the resulting data difficult to compare [59]. INFOGEST is an action
granted by the European Cooperation in Science and Technology (COST) and was developed to help
overcome this hurdle. INFOGEST is a static in vitro digestion model which aims to harmonise the
methods used to assess digestibility, allowing for better comparisons between studies [60,61].
Various in vitro cell culture methods have been utilised to simulate a food component’s ability to
be assimilated within the intestine, the first component within bioactivity (Figure 1). Caco-2 cells, a cell
line derived from human colonic adenocarcinoma, are by far the most commonly used [52,62]. HT-29
is another human colon carcinoma cell line that has been used to study epithelial transport, although it
is rarely used [63]. The co-culture of Caco-2 cells with a human mucous-producing cell line, such as
HT29-MTX, has been suggested to more closely resemble in vivo conditions [64].
Similar to the previously described in vivo protein quality studies [43,44], in vitro bioaccessibility
studies also appear to suggest that unprocessed seaweed proteins have reduced digestibility compared
to that of other protein sources. For example, the seaweed species P. tenera, U. pinnatifida, and
Ulva pertusa have reported in vitro bioaccessibility of 78%, 87%, and 95%, respectively, expressed
as a percentage of casein bioaccessibility (100%) [3]. U. lactuca has been shown to have an in vitro
digestibility of 85.7% ± 1.9%, while the red seaweeds Hypnea charoides and H. japonica have high
digestibility of 88.7% ± 0.7% and 88.9% ± 1.4%, respectively [65]. Comparable results for U. lactuca
were found with in vitro simulated ileal digestibility of 82.3% [66]. Tibbetts and colleagues (2016)
reported significantly greater in vitro digestibility in red seaweeds (83%–87%) compared to brown
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seaweeds (78.7%–82%) [67]. These results demonstrate that seaweed proteins have comparable in vitro
digestibility compared to that of other commonly consumed plants, including grains (69%–84%),
legumes (72%–92%), fruits (72%–92%), and vegetables (68%–80%) [67].
The digestibility of microalgae is poorly examined within the literature, including in vitro
bioaccessibility studies. However, microalgae appear to have similar digestibility to that of seaweed,
with Scenedesmus obliquus, Spirulina sp., Chlorella sp. having digestibility coefficient values of 88.0%,
77.6%, and 76.6%, respectively [28]. This is in comparison to protein sources such as casein and egg
with a digestibility coefficient of 95.1% and 94.2%.
3. Protein Extraction Methods
3.1. Conventional Protein Extraction Methods
Seaweed and microalgae have poor protein digestibility in their raw, unprocessed form and it is
for this reason that great emphasis has been placed on developing improved methods for algal
protein extraction in order to improve their bioavailability. Algal proteins and their extraction
is a relatively poorly studied topic compared to proteins from other crops [68]. Algal proteins
are conventionally extracted by means of aqueous, acidic, and alkaline methods, followed by
several rounds of centrifugation and recovery using techniques such as ultrafiltration, precipitation,
or chromatography [69]. Chemical extraction methods, such as two-phase acid and alkali treatments,
have been especially efficient for extracting proteins from A. nodosum, Ulva spp. and L. digitata
(Table 1) [69–71].
However, the successful extraction of algal proteins can be greatly influenced by the availability
of the protein molecules, which can be substantially hindered by high viscosity and anionic
cell-wall polysaccharides, such as alginates in brown seaweed and carrageenans in red seaweed [72].
Cell disruption methods and the inclusion of selected chemical reagents are therefore used in order
to improve the efficiency of algal protein extraction. Some examples of conventional methods
that are commonly utilised include mechanical grinding, osmotic shock, ultrasonic treatment, and
polysaccharidases-aided hydrolysis (Table 1) [73].
Table 1. Conventional pre-treatment cell disruption methods and extraction methods for precipitating
proteins from seaweed. Dry weight; dw.
Extraction
Method Species Extraction Name Reagents Protein Yield Reference
Enzymatic
hydrolysis
Palmaria palmata Polysaccharidasedegradation
Cellulase (Cellucast®) and
xylanase (Shearzyme®)
Factor 3.3 compared to
control [46]
Chondrus crispus,
Gracilaria verrucosa,
and Palmaria palmata
Polysaccharidase
degradation
κ-carrageenase, β-agarase,
xylanase, cellulase - [74]
Palmaria palmata Polysaccharidasedegradation
Cellulase (Cellucast®),
xylanase (Shearzyme®) and
Ultraflo® (β-glucanase)
11.57 ± 0.08 g/100 g dw
(67% yield) [73]
Physical
Process
Porphyra acanthophora
var. acanthophora,
Sargassum vulgare
and Ulva fasciata
Aqueous treatment
and Potter
homogenisation
Ultra-pure water
8.9 g/100 g dw,
6.9 g /100 g dw,
7.3 g /100 g dw
[68]
Palmaria palmata Osmotic stress -
6.77 ± 0.22 g/100 g dw
(39% yield) [73]
High shear force - 6.92 ± 0.12 g/100 g dw(40% yield)
Chemical
extraction
Ascophyylum nodosum Acid-alkalinetreatment 0.4 M HCl and 0.4 M NaOH 59.76% yield [69]
Ulva rigida Two-phase system NaOH and 2-mercaptoethanol - [70]Ulva rotunda
Laminaria digitata Two-phase system Polyethylene glycol (PEG) andpotassium carbonate - [71]
Palmaria palmata Alkaline andaqueous
NaOH and N-acetyl-
L-cysteine (NAC)
4.16 g/100 g dw
(24% yield) [73]
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3.1.1. Physical Processes
Barbarino and Lourenço (2005) reported that physical grinding with the use of a Potter
homogeniser significantly increased protein extraction yield from Porphyra acanthophora var.
acanthophora, Sargassum vulgare, and Ulva fasciata following immersion in ultra-pure water (Table 1) [68].
Alternatively, osmotic stress has also been reported to improve extraction of algal proteins
efficiency [45,75]. Osmotic shock was reported to yield a significantly higher concentration of water
soluble proteins from P. palmata (1.02 ± 0.07 g/100 g) compared to high shear force with an
Ultra-turrax® T25 Basic tool (IKA®, Staufen, Germany) (0.74 ± 0.02 g/100 g) [73]. However, there was
no significant difference in the amount of total protein extracted between the two methods (6.77 versus
6.92 g/100 g). Alternatively, the use of polysaccharidases was reported to be a more promising method
of protein extraction, with a concentration of 11.57 ± 0.08 g/100 g P. palmata, equating to a yield of 67%
(Table 1) [73].
3.1.2. Enzymatic Hydrolysis
Seaweed is rich in several types of polysaccharides, including cellulose, galactans, xylans,
fucoidan, laminarin, alginates, carrageenans, and floridean starch [22]. These polysaccharides can
reduce the availability of algal proteins and decrease protein extraction efficiency [68]. Enzymes
such as polysaccharidases can therefore be applied as a cell disruption treatment prior to protein
extraction in order to increase protein yield (Table 1). Several polysaccharidases (κ-carrageenase,
β-agarase, xylanase, cellulase) were used in protein extractions from the red seaweed species C. crispus,
Gracilaria verrucosa, and P. palmata as a method of combating the tough cell wall [74]. Hydrolysis of
C. crispus with carrageenase and cellulase increased protein yield ten-fold compared to the enzyme-free
procedure, while the highest yield from P. palmata was obtained with xylanase. Similarly, hydrolysis
of P. palmata with xylanase and cellulase was demonstrated to yield a ten-fold increase in the
phycoerythrin pigment protein compared to mechanical extraction [46]. Harnedy and Fitzgerald
(2013) also increased protein yield from P. palmata with xylanase, although they reported that the high
enzyme:substrate concentration required (48.0 × 103 units/100 g) may not be commercially feasible at
an industrial scale. Combining multiple extraction methods may also help to improve algal protein
extraction. Combining enzymatic hydrolysis with alkaline extraction increased protein yield 1.63-fold
compared to alkaline extraction alone in P. palmata [76].
3.2. Current Protein Extraction Methods
Protein extraction methods used on algae to date are limited for commercial use due to concerns
with up-scaling. Conventional mechanical and enzymatic methods for protein extraction may also
affect the integrity of extracted algal proteins due to the release of proteases from cytosolic vacuoles [77].
Furthermore, these methods are also laborious and time consuming [69]. Improved extraction methods
of cell disruption and extraction are therefore required. Pre-treatment with cell-disruption techniques
aid the breakdown of the tough algal cell wall, increasing the availability of proteins and other
high-value components for later protein extraction. Some examples of novel protein extraction methods
include ultrasound-assisted extraction, pulsed electric field, and microwave-assisted extraction [13].
3.2.1. Ultrasound-Assisted Extraction
Ultrasound-assisted extraction (UAE) can be applied to food sources for a number of applications,
including modification of plant micronutrients to improve bioavailability, simultaneous extraction and
encapsulation, quenching radical sonochemistry to avoid degradation of bioactives, and increasing
bioactivity of phenolics and carotenoids by targeted hydroxylation [78]. The degradative effect of
radical sonochemistry, which is the most relevant aspect in terms of improving bioavailability of algal
proteins, is not produced by the ultrasound waves, but rather by the formation, growth, and implosion
of bubbles formed by what is known as acoustic cavitation [79]. The violent implosion of these bubbles
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creates microscopic regions of extreme pressure and temperature, resulting in the chemical excitation of
the sonicated liquid and its contents, facilitating the particle breakdown and degradation of the target
compound [80]. The major advantages of UAE are its fast processing time, non-thermal properties,
and low solvent consumption, resulting in a higher purity final product with reduced downstream
processing required [81].
Ultrasound pre-treatment was reported to increase protein extraction of Ascophyllum nodosum
with acid and alkaline treatment alone by 540% and 27%, respectively, as well as reduce processing
time from 60 min to 10 min [69]. This dramatic increase in protein yield was suggested to be due to acid
hydrolysis alone being insufficient to erode the tough cell wall. Ultrasound-aided extraction was also
evaluated in microalgae for a number of value-added components, although there have been relatively
few studies that have focused on ultrasound for improved protein extraction [82,83]. Keris-Sen and
colleagues (2014) reported that ultrasound at a power intensity of 0.4 kWh·L−1 yielded the optimum
concentrations of proteins from wastewater treatment microalgae from the Chlorococcales order of
the Chlorophyceae class (e.g., Scenedesmus sp.) [84]. Ultrasound treatment of C. vulgaris significantly
increased crude protein digestibility in rats compared to electroporated and untreated spray-dried
C. vulgaris (56.7% ± 13.7%, 44.3% ± 7.5%, and 46.9% ± 12.7%, respectively), as well as significantly
improving protein efficiency ratio and nitrogen balance [85]. Additionally, there were no adverse effects
to the histology of major organs upon prolonged consumption of ultrasound-treated microalgae, and
thus it has been suggested as a viable pre-treatment method for the food industry [86]. Alternating two
counter-current frequencies has also been suggested as a viable method for further improving protein
extraction, as demonstrated by a 50% increase in yield and 18% reduction in extraction time using 15
and 20 kHz in Porphyra yezoensis compared to mono-frequency ultrasound-assisted extraction [87].
3.2.2. Pulsed Electric Field
Pulsed electric field (PEF) has been used as a cell disruption technique in microalgae, although its
primary use has thus far been for the extraction of lipids for conversion to biofuel [88]. PEF involves
applying high electric currents in order to perforate a cell wall or cell membrane, causing reversible
or irreversible electroporation [88]. Electroporation enables the introduction of various foreign
components to cells, including DNA, proteins, and drugs [89]. PEF is a fast and green technology
for inactivating microorganisms by irreversible electroporation and aiding the release of intracellular
contents of plant cells [90,91]. However, conductivity and electrode gap are factors that could possibly
limit this technology for up-scaling [92].
Goettel and colleagues (2013) were among the first to report the use of PEF as a means of
extracting multiple intracellular components from algae [93]. Since then, PEF has been demonstrated
to increase the yield of several high-value microalgae components, including lipids, carbohydrates,
carotenoids and chlorophyll [94–98]. Protein yield from Chlorella sp. and Spirulina sp. was reported
to increase by 27% and 13%, respectively, following PEF-treatment at 15 kV/cm and 100 kJ/kg [99].
Coustets and colleagues (2013) also reported significantly increased protein extraction in C. vulgaris and
Nannochloropsis salina following PEF-assisted extraction, allowing for the extraction of intact cytosolic
proteins [100].
3.2.3. Other
Microwave-assisted extraction (MAE) involves heating a material, causing moisture to evaporate,
thus creating bubbles under high pressure which can then rupture to disrupt cell contents [82].
Increased levels of soluble proteins were extracted from a microalgae biomass containing green
microalgae (Stigeoclonium sp. and Monoraphidium sp.) and diatoms (Nitzschia sp. and Navicula sp.)
using microwave pre-treatment compared to ultrasound [101]. MAE has attracted attention for
extraction of compounds due low energy efficiency, although its use in algae may be limited by
impaired function with dried samples [81].
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Alternatively, sub- and supercritical fluid extraction techniques have gained popularity in
recent decades as extraction methods. Subcritical water extraction (SWE) involves using hot water
(100–374 ◦C) under high pressure (~10 bar) to maintain water in a liquid state [102]. Alternatively,
supercritical fluid extraction (SFE) is a technique that heats a fluid above its critical point, making
it supercritical. Under supercritical conditions, the properties of the fluid become indistinguishable
from its gaseous state, with a density similar to a fluid, but viscosity matching that of gas [102]. SFE
typically utilises carbon dioxide (CO2), making it a relatively ‘green’ technology with low solvent
consumption [81]. However, SWE and SFE both require high investment costs for equipment and have
typically only been used in algae to date for the extraction of lipids [102].
3.3. Enrichment Methods—Membrane Filtration
Membrane technologies are widely used in the dairy industry to recover whey proteins from milk
released as a result of the cheese-making process [103]. Membrane technology refers to the use of a
semi-permeable membrane to separate a liquid into two different fractions by selectively allowing
some compounds to pass through while impeding other compounds, typically based on molecular
weight. Membrane technologies are promising alternative methods of enriching algal proteins, as well
as developing novel techno-functional and bioactive ingredients. They have the advantage of being
non-thermal and environmentally-friendly [103]. The most commonly used membrane technologies
include microfiltration, ultrafiltration, nanofiltration, and reverse osmosis.
Membrane technologies could act as an alternative method for enriching algal proteins when
used in conjunction with a cell disruption technique, such as polysaccharidase hydrolysis, UAE, or PEF.
Disruption of the tough cell wall is a critical step required in order to increase the availability of algal
proteins for extraction [82]. Membrane technologies are well suited for use with seaweed as part of a
cascading biorefinery process to maximise valorisation of all components within algae, while avoiding
the presence of heavy metals in the final product [104]. A combination of membrane technologies
could be used to isolate algal proteins using the same principles of molecular weight cut-offs used
in the dairy industry. In the dairy industry, microfiltration (MF) is used to extend the shelf-life of
milk without any thermal treatment by removing microorganisms, while preserving overall taste and
sensory attributes [105]. MF could be used to remove algae cell wall components and bacteria with
a molecular weight greater than 200 kDa. Ultrafiltration (UF) could then be used to isolate proteins
and other macromolecules between 1 and 200 kDa, similar to the way it is used in the dairy industry
to generate enriched fractions less than 10, 5, 3 and 1 kDa. Nanofiltration (NF) could then be used to
remove monovalent salts to minimise osmotic pressure, followed by reverse osmosis (RO) to reduce
fluid volume [103].
Indeed, membrane technologies have already been used to isolate whole microalgae cells
and several seaweed components. Tangential flow microfiltration was reported as an efficient
method for recovering 70%–89% of algal biomass from wastewater treatments [106]. UF was
previously used in conjunction with supercritical CO2 extraction and ultrasound to isolate
Sargassum pallidum polysaccharides [107]. Polysaccharides with antioxidant activities were isolated
from U. fasciata utilising hot water extraction followed by several stages of ultrafiltration with
increasingly smaller pore sizes [108]. Furthermore, UF was used to isolate phycoerythrin protein from
Grateloupia turuturu following cell homogenisation, which was reported to retain 100% of the protein
without denaturation [109]. Alternatively, a two-stage ultrafiltration could be applied for algal protein
enrichment, as demonstrated by the separation of polysaccharide components in Tetraselmis suecica
using different sized pore membranes following high-pressure homogenisation [110].
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4. Applications
4.1. Human Nutrition
Protein is an essential nutritional component in the diet of athletes, required to repair and build
muscle tissue broken down during exercise, with the American College of Sports and Medicine
recommending between 1.2 and 1.7 g protein per kg body weight [111]. Seaweed and microalgae are
rich sources of protein and contain all of the essential amino acids at various concentrations [112].
Algae could therefore represent a valuable resource for athletes requiring high levels of protein,
especially for vegan athletes for whom eggs and dairy whey protein may not be suitable [113].
Seaweed and microalgae have been used as a source of human nutrition for thousands of years in
some indigenous populations [114]. One of the main reasons for the high consumption of seaweed
and microalgae is due to their significant protein content, which is comparable to, or even greater than,
some plant sources [28]. Some species of red seaweeds (Rhodophyta), such as P. palmata and P. tenera,
have been reported to contain as much as 33% and 47% dw, respectively [3]. Similarly, some species of
microalgae have been reported to contain even higher levels, as high as 63% dw in Spirulina sp. [115].
Microalgae are typically consumed as a dietary supplement in the form of powder, pills, or tablets [9].
However, they have also been incorporated into a number of functional foods, including noodles,
bread, biscuits, drinks, sweets, and beer [116]. Several businesses have been set up for the sale of algal
products, such as AlgaVia® (www.algavia.com), which produces protein- and lipid-rich algal flour
from Chlorella protothecoides.
There are several species of seaweed that have traditionally been consumed, largely due to their
high protein content. For example, P. tenera (nori) is commonly used as a sushi wrap in several
Asian cultures [22]. Many species of seaweed are particularly high in the amino acids aspartic acid
and glutamic acid, which exhibit a unique and interesting flavour that led to the discovery of the
taste sensation referred to as ‘umami’ [40]. The flavour enhancer monosodium glutamate was first
discovered in the brown seaweed L. japonica (kombu), which has been found to particularly appeal to
the umami taste sensation [117].
Although the consumption of seaweed in humans is currently underdeveloped, especially in
Western countries, the high protein content and favourable essential amino acid profile makes seaweed
a promising source of protein that is ripe for future expansion [40]. Seaweed has been successfully
incorporated as a functional ingredient into several foods at the laboratory scale. U. pinnatifida
(wakame) integrated into pasta has antioxidant activity and acceptable sensory attributes at levels up
to 10% [118]. Bread containing 4% A. nodosum can significantly reduce energy intake in overweight
individuals in the meal following enriched bread consumption [119]. Bread incorporating similar
concentrations of renin-inhibitory peptides from P. palmata hydrolysates also had acceptable sensory
attributes, with the bioactive properties reported as having survived the baking process [120].
Spirulina is the most highly consumed microalgae due to its high protein content and
added nutritional benefits, including anti-hypertension, renal protective, anti-hyperlipidaemia,
and anti-hyperglycaemic [121]. As well as being a rich source of proteins, Spirulina contains
high levels of hypocholesterolemic γ-linoleic acid (GLA), B-vitamins, and free-radical scavenging
phycobiliproteins [122]. It has therefore been given the label of a ‘super food’ by the World Health
Organisation (WHO) and has even been sent to space by the National Aeronautics and Space
Administration (NASA) due to its nutrient-dense properties [123]. As a demonstration of this, Spirulina
has 180% more calcium than milk, 670% more protein than tofu, 3100% more β-carotene than carrots,
and 5100% more iron than spinach [27]. The world’s largest producer of Spirulina is Hainan Simai
Enterprising Ltd., which is located in the Hainan province of China [121]. This cultivation farm
produces an annual 200 tonnes dried biomass, accounting for 25% of the national output and a
considerable 10% of the global production. Alternatively, the Earthrise Company has the largest
Spirulina production plant, which is located in California, USA, and covers 440,000 m2 [121].
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Chlorella is another widely consumed microalga, with global sales exceeding US $38 billion [124].
The largest producer of Chlorella is Taiwan Chlorella Manufacturing and Co. (Taipei, Taiwan), which
produces 400 tons dried biomass annually [121]. The main substance found in Chlorella that is beneficial
for human health is β-1,3-glucan, which is an active immunostimulant, free-radical scavenger and
reducer of blood lipids [125]. Chlorella is also rich in proteins (48% dw), polyunsaturated fatty acids
(PUFAs) (39% of total lipids), and phosphorus (1761.5 mg/100g dw) [115].
4.2. Industrial Applications
Lectins and phycobiliproteins are two families of bioactive algal proteins which have been
exploited for several industrial applications. Lectins are most commonly extracted from macroalgal
sources, while phycobiliproteins are typically isolated from microalgae [126]. Phycobiliproteins,
especially phycoerythrin, can constitute a significant proportion of the overall protein content in red
algae, with levels of 1.2% (total dw) reported for P. palmata [127]. Lectins are found at similar levels
and a yield of 1% lectins was obtained previously from Eucheuma serra (Rhodophyta) [128].
4.2.1. Lectins
Lectins are glycoproteins known for their aggregation and high specificity binding with
carbohydrates without initiating modification through associated enzymatic activity [129]. Lectins are
involved in several biological processes, including host-pathogen interactions, cell–cell communication,
induction of apoptosis, cancer metastasis and antiviral activities [130]. Due to their carbohydrate
binding capacity with high specificity, lectins are used in blood grouping, anti-viral (including human
immunodeficiency virus type 1(HIV-1)), cancer biomarkers, and targets for drug delivery [131].
Lectins derived from algae have not received the same level of characterisation compared to other
plant-derived lectins. Nevertheless, some of the bioactivities that have been observed in algal lectins
include mitogenic, cytotoxic, antibacterial, anti-nociceptive, anti-inflammatory, anti-viral (HIV-1),
platelet aggregation inhibition, and anti-adhesion [132].
4.2.2. Phycobiliproteins
Phycobiliproteins are water-soluble proteins with an important role in photosynthesis
within cyanobacteria, Rhodophyta, and cryptomonads [133]. Phycobiliproteins are components
of phycobilisomes, which are large light energy-capturing complexes anchored to thylakoid
membranes [134]. There are four main divisions of phycobiliproteins which are grouped based
on their colour and absorption characteristics, namely, phycoerythrin, phycocyanin, allophycocyanin,
and phycoerythrocyanin [135]. The main commercial producers are Spirulina sp. (cyanobacterium)
and Porphydrium sp. (Rhodophyta macroalgae) [121].
Phycobiliproteins are used in fluorescent labelling, flow cytometry, fluorescent microscopy, and
fluorescent immunohistochemistry [136,137]. However, the primary commercial application of these
phycobiliproteins appears to be as natural dyes, with phycocyanin in particular used as a blue pigment
used in products such as chewing gum, popsicles, confectionary, soft drinks, dairy products, and
wasabi, as well as cosmetic products, such as lipstick and eyeliner [121]. Several patents concerning
health beneficial bioactivities of phycobiliproteins have also already been filed for nutraceutical
applications such as anti-oxidative, anti-inflammatory, anti-viral, anti-tumour, neuroprotective, and
hepatoprotective activities [135].
4.3. Animal Feed
The high protein content of algae can also be beneficial for use as animal feed, including
aquaculture, farm animals, and pets. An estimated 30% of global algal production is estimated
to be used for animal feed, with 50% of Spirulina biomass in particular used as feed supplement due to
its excellent nutritional profile [124,138]. Several species of microalgae including Spirulina, Chlorella,
and Schizochytrium sp., and seaweed including Laminaria sp. and Ulva sp. can be incorporated as
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protein sources into the diets of poultry, pigs, cattle, sheep, and rabbits [4,139]. Most of the research
on the incorporation of algae as animal feed has been carried out with poultry, likely due to their
promising prospects for improved commerciality [138].
Tasco® is an example of a proprietary seaweed meal derived from A. nodosum, produced
by Acadian Seaplants in Nova Scotia, Canada (http://www.acadianseaplants.com), which has
demonstrated beneficial properties when included in animal feed [140]. Tasco® has four main
identified benefits for animal production, including resistance to stressors, improved immune system,
increased productivity/quality, and a reduction in pathogenic microorganisms in the final meat
product [141–144]. These benefits have been observed in several species, including monogastric and
ruminant species, when at feed inclusion levels of 2% on a daily basis [145].
4.3.1. Poultry
Supplementing poultry feed with microalgae as a protein source can improve their health,
productivity, and value. This has been demonstrated using a variety of species, including Chlorella
sp., Arthrospira sp., Porphyridium sp., and Haematococcus sp. [86,139,146,147]. Chickens fed with
supplemented Spirulina have been reported to have increased viability, improved overall health and
reduced plasma concentrations of cholesterol, triglycerides, and fatty acids [148]. These birds also
appeared to have an improved immune system as demonstrated by a significant increase in white
blood cell count and enhanced macrophage phagocytic activity [148,149]. Ross and Dominy (1990)
reported that feeding White Leghorn cockerel chicks, Hubbard by Hubbard male broiler chicks, and
Japanese quail with varying concentrations of Spirulina in dietary feed slightly delayed growth rates,
but did not affect final growth at concentrations less than 10% [150]. Furthermore, this study also
reported that the inclusion of Spirulina also increased fertility rates, as well as increasing the intensity
of the egg-yolk colour [150]. These results have been confirmed by several other studies, indicating
that the inclusion of Spirulina at a concentration of 2%–2.5% in the feed intensifies the colour of egg
yolks to make it more esthetically pleasing for consumers [151,152]. The intensified colouration of
the yolk is thought to be due to β-carotene [153]. The inclusion of Spirulina can also further valorise
egg products by decreasing their cholesterol and saturated fatty acid content, and replacing it with
increased levels of beneficial omega-3 polyunsaturated fatty acids [146,154].
Incorporation of 3% U. lactuca in broiler chickens increased breast muscle yield compared to birds
solely fed corn diet, as well as decreased serum lipids, cholesterol, and uric acid concentrations [155].
The red seaweed Polysiphonia spp. was also demonstrated to improve pellet binding in duck feed at
concentrations of 3%, as well as improve its overall nutrient profile [156]. The incorporation of red
seaweeds C. crispus and Sarcodiotheca gaudichaudii was also reported to effectively act as a prebiotic to
improve chicken gut health, productivity, and egg quality [157].
4.3.2. Pigs
The replacement of up to 33% of soy proteins with proteins from Arthrospira maxima, A. platensis,
and C. vulgaris in pig feed has been reported as being suitable without any adverse effects [158].
The effect of feed processing appears to play a role in the utility of Spirulina in pig’s feed. The addition
of Spirulina to pellets was reported to decrease average daily gain, whereas incorporation of Spirulina
to meal diets actually increased average daily gain [159]. Addition of Spirulina to the diet has also been
suggested to improve fertility in pigs, increasing sperm motility and storage viability [160].
Supplementation of the brown seaweed L. digitata increased pig body weight gain by 10%, as well
as increase the concentration of iodine in fresh muscle by 45%, thus increasing its valorisation [161].
Similarly, A. nodosum has also been reported to increase iodine content in pig tissue, while also
increasing the concentrations of beneficial bacteria within the gut [162]. However, these results
are in contrast to the findings of Reilly and colleagues (2008), who reported that the brown
seaweeds Laminaria hyperborea and L. digitata actually decreased the biodiversity of beneficial microbial
populations within the pig’s gut, although this did not significantly affect the pig’s performance [163].
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4.3.3. Ruminants
Of all the animals evaluated for algae supplementation, ruminants are the most promising in terms
of digesting the high fibre content for the greatest extraction efficiency of algal proteins [139]. This is in
contrast to mono-gastric animals, for which it has been suggested that some form of prior processing
may be required in order for animals (and humans) to utilise algal proteins more efficiently [164]. Cattle
will preferentially drink water containing 20% suspended Spirulina, increasing their daily water intake
by 24.8 g/kg [165]. Furthermore, this study also reported that 20% of the consumed Spirulina bypasses
degradation within the rumen, allowing for increased digestion and absorption of protein and nutrients
within the abomasum [165]. Incorporation of 200 g/day Spirulina with cattle feed was reported to
be an economically effective method of increasing animal body weight (8.5%–11%) and daily milk
production (21%) [166]. As well as increasing milk quantity, Spirulina supplementation has also been
demonstrated to increase milk quality by decreasing saturated fatty acids, while simultaneously
increasing monounsaturated fatty acids and polyunsaturated fatty acids [167]. Similar results were
observed in other studies, as well as with supplementation of Schizochytrium sp. [168,169].
Sheep have also been demonstrated to benefit from microalgae as a protein source, with lambs
reported to have increased average daily gains upon consumption of 10 g of Spirulina per day [170].
Similarly, Spirulina diet supplementation increased the feed intake of rabbits, as well as improve the
quality of rabbit meat with higher levels of GLA [171]. The green seaweed U. lactuca has been reported
as a suitable low-energy, high-protein foodstuff for sheep and goats [172,173]. However, seaweed
may be not be suitable for supplementation in pregnant ewes, having been reported to interfere with
passive immunity in lambs and increasing mortality rate [174].
4.4. Aquaculture
Microalgae are vital for the artificial reproduction of several aquaculture species, especially
molluscs [138]. Microalgae also play an important role in aquaculture, other than as a food source
for zooplanktons by stabilising pH, reducing bacterial growth, and improving the quality of rearing
medium [175]. This leads to improved survival and growth compared to that of clear water fed with
artificial diets [176]. Microalgae are the natural base of the entire aquatic food chain. This has led
to their widespread incorporation as an important food source and feed additive in the commercial
rearing of many aquatic animals, including molluscs, shrimp, and rotifers [177]. Filtering molluscs
are by far the greatest consumer of microalgae in aquaculture, with 10.1 × 106 tonnes produced in
1999, compared to shrimp (1.2 × 106 tonnes), and small larvae fish, such as sea breams and flatfish
(177,400 tonnes) [178].
Replacements of live microalgae are already commercially available (such as Chaetoceros 1000
“Premium Fresh” Instant Algae™ paste, Liqualife™ liquid larval feed, Zeigler™ E-Z Larvae liquid
feed, and Zeigler™ Z-Plus feed), but typically provide inferior growth and survival rates [179].
For example, the survival rate of brown larval shrimp (Farfantepenaeus aztecus) significantly decreased
from 90.86 ± 3.19% when fed live microalgae, to 14.865± 14.35% in shrimp fed with 100% replacement
E-Z larvae [179].
Microalgae are also often used as a dietary supplement to refine the products of aquaculture and
increase their valorisation. Carotenoid pigments, such as astaxanthin derived from Haematococcus pluvalis,
are incorporated into the diets of salmonoids, shrimp, lobsters, and crayfish, to give them their
characteristic pink flesh [180]. Similarly, inclusion of astaxanthin at a concentration of 30 ppm
significantly increases the colour pattern and intensity of ornamental fish, including tetras, cichlids,
gouramis, damos, goldfish, and koi, increasing their market value several fold [147].
Red seaweed has been suggested as a promising protein source feed additive. Incorporating 10%
Gracilaria chilensis in the diet of Atlantic salmon (Salmo solar) was reported to significantly increase
specific growth rate by 1.51% ± 0.12% compared to the control diet [181]. Including 1.0% and 10%
G. chilensis in the diets of S. solar was also suggested to increase antiviral activity against the infectious
salmon anaemia (ISA) virus. Similarly, inclusion of 5% and 15% P. palmata was reported to improve
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hepatic function and have a positive effect on body lipid content in S. salar compared to the control
diets [182]. Wild abalone are opportunistic feeders that consume a variety of macroalgae species
and typically have increased growth rate in captivity when fed a diet with several species compared
to single species diets [183]. Haliotis tuberculata coccinea fed with a mixed diet including Ulva rigida,
Hypnea spinella, and Gracilaria cornea displayed significantly greater growth rates, length, and weight
gain than diets consisting of single algal species [184]. Seaweed is also often used in the feed of
sea cucumber culture systems, which are used for human consumption in many Asian countries.
L. japonica and U. lactuca have been reported as an economical additive to the diets of sea cucumber
Apostichopus japonicas with low ammonia–nitrogen production and suitable digestibility [185].
4.5. Bioactive Peptides
Bioactive peptides are particular amino acid sequences that can have additional physiological
health benefits beyond their basic nutritional value [126]. These peptides are typically between 2 and
30 amino acids in length and have hormone-like properties. Bioactive peptides are inactive within
the parent proteins, but can be released through fermentation or hydrolysis. Milk proteins remain the
most common source for bioactive peptides [186,187]. However, bioactive peptides have also been
identified in a number of food sources, including meat, egg, fish, and blood, as well as plant sources,
including rice, soybean, wheat, pea, broccoli, garlic, and algae [132,188–197].
Bioactive peptides have been found to have a multitude of beneficial effects, including
anti-hypertensive, anti-oxidative, antithrombotic, hypocholesterolemic, opioid, mineral binding,
appetite suppression, anti-microbial, immunomodulatory, and cytomodulatory properties [187].
Bioactive peptides from algae have also been found to display bioactive properties, although they
are not as well characterised compared to peptides from other sources (Table 2) [198]. Antimicrobial
peptides have been identified from Saccharina longicruris protein hydrolysates, significantly decreasing
the growth rate of Staphylococcus aureus [199]. The hexapeptide Glu-Asp-Arg-Leu-Lys-Pro isolated
from Ulva sp. was demonstrated to have mitogenic activity in skin fibroblasts [200].
Table 2. Angiotensin-I-converting enzyme (ACE)-I inhibitory bioactive peptides derived from seaweed
and microalgae. The potency of the peptides is indicated by their IC50 values, which refers to the
concentration required to inhibit enzyme activity by 50%.
Source Hydrolytic Method Peptide Sequence IC50 Reference
Undaria pinnatifida
(wakame)
Pepsin
Ala-Ile-Tyr-Lys 213 µM
[201]
Tyr-Lys-Tyr-Tyr 64.2 µM
Lys-Phe-Tyr-Gly 90.5 µM
Tyr-Asn-Lys-Leu 90.5 µM
Undaria pinnatifida
(wakame) Hot water extraction
Tyr-His 5.1 µM
[202]
Lys-Trp 10.8 µM
Lys-Tyr 7.7 µM
Lys-Phe 28.3 µM
Phe-Tyr 3.7 µM
Val-Trp 10.8 µM
Val-Phe 43.7 µM
Ile-Tyr 2.7 µM
Ile-Trp 12.4 µM
Val-Tyr 11.3 µM
Undaria pinnatifida
(wakame) Protease S “Amano”
Val-Tyr 35.2 µM
[203]
Ile-Tyr 6.1 µM
Ala-Trp 18.8 µM
Phe-Tyr 42.3 µM
Val-Trp 3.3 µM
Ile-Trp 1.5 µM
Leu-Trp 23.6 µM
Ecklonia cava
Alcalase Enzymatic digest 2.79 µg/mL
[204]
Flavourzyme Enzymatic digest 3.56 µg/mL
Kojizyme Enzymatic digest 2.33 µg/mL
Neutrase Enzymatic digest 3.10 µg/mL
Protamex Enzymatic digest 3.28 µg/mL
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Table 2. Cont.
Source Hydrolytic Method Peptide Sequence IC50 Reference
Porphyra yezoensis
Ile-Tyr 2.69 µM
[205]
Met-Lys-Tyr 7.26 µM
Ala-Lys-Tyr-Ser-Tyr 1.52 µM
Leu-Arg-Tyr 5.06 µM
Hizikia fusiformis
Gly-Lys-Tyr 3.92 µM
[206]Ser-Val-Tyr 8.12 µM
Ser-Lys-Thr-Tyr 11.07 µM
Palmaria palmata (dulse) Thermolysin
Val-Tyr-Arg-Thr 0.14 µM
[207]
Leu-Asp-Tyr 6.1 µM
Leu-Arg-Tyr 0.044 µM
Phe-Glu-Gln-Trp-Ala-Ser 2.8 µM
Chlorella vulgaris
Pepsin
Ile-Val-Val-Glu 315.3 µM
[208]
Ala-Phe-Leu 63.8 µM
Phe-Ala-Leu 26.3 µM
Ala-Glu-Leu 57.1 µM
Val-Val-Pro-Pro-Ala 79.5 µM
Arthrospira platensis
Ile-Ala-Glu 34.7 µM
Phe-Ala-Leu 11.4 µM
Ala-Glu-Leu 11.4 µM
Ile-Ala-Pro-Gly 11.4 µM
Val-Ala-Phe 35.8 µM
Nannochloropsis oculata Alcalase Leu-Val-Thr-Val-Met 18.0 µM [209]
Nannochloropsis oculata Pepsin Gly-Met-Asn-Asn-Leu-Thr-Pro 123 µM [210]Leu-Glu-Gln 173 µM
Chlorella ellipsoidea
Protamex, Kojizyme, Neutrase,
Flavourzyme, Alcalase, trypsin,
α-chymotrypsin, pepsin, and papain
Val-Glu-Gly-Tyr 128.4 µM [211]
Chlorella vulgaris Flavourzyme, alcalase, papain, and pepsin Val-Glu-Cys-Tyr-Gly-Pro-Asn-Arg-Pro-Gln-Phe 29.6 µM [212]
Owing to the high levels of oxidative stresses and free radicals in their environment, microalgae
and seaweed have developed many defensive systems that can stimulate antioxidant activity when
consumed [213]. Antioxidant peptides have therefore been isolated from several species of microalgae,
including C. vulgaris, Navicula incerta, and Chlorella ellipsoidea [214–217]. Antioxidant peptides have also
been isolated from various Irish and Korean brown seaweeds, which indicated that those with higher
phenolic content, such as Ecklonia cava and Sargassum coreanum, correlated with increased antioxidant
activity [218–220]. Peptides displaying antioxidant and anticancer bioactivity have also been reported
in Sri Lankan red and green seaweed, of which Caulerpa racemosa demonstrated the most promising
free radical scavenging and anticancer bioactivity [221].
Microalgae have also been reported to display anticancer peptides, such as Chlorella pyrenoidosa
antitumor polypeptide (CPAP) derived from Chlorella pyrenoidosa and polypeptide Y2 derived from
A. platensis [222,223]. Protein hydrolysates from Porphyra columbina phycocolloid extraction by-products
were reported to have immunosuppressive, anti-hypertensive, and antioxidant capacities [224].
Anti-inflammatory peptides have been isolated from microalgae, such as Chlorella 11-peptide derived
from C. pyrenoidosa [225], as well as peptides derived from A. maxima (Leu-Asp-Ala-Val-Asn-Arg
and Met-Met-Leu-Asn-Phe), which were additionally reported to display anti-atherosclerosis
bioactivity [226,227]. Similarly, anti-atherosclerosis peptides have also been isolated from P. palmata
and were shown to be non-toxic in Zebrafish at a concentration of 1 mg/mL [228].
Algal peptides have been reported to display several other bioactivities, including
hepatoprotective, immunomodulatory, ultraviolet (UV) radiation-protective, anti-osteoporosis, and
anti-coagulant [229–234]. Finally, it is important to note that several studies have reported that short
algae-derived peptides are capable of resisting gastrointestinal digestion from enzymes such as trypsin,
pepsin, and chymotrypsin [203,207,235]. This is an essential trait for bioactive peptides in order to
achieve their physiological effect at their site of action [236].
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Anti-Hypertensive Peptides
Hypertension is the single largest risk factor attributed to deaths worldwide, making it an
ideal target for bioactive peptides [237]. Angiotensin-I-converting enzyme (ACE-I) is a proteolytic
enzyme that affects vasoconstriction in two major blood pressure regulatory systems, namely
renin-angiotensin–aldosterone system (RAAS) and kinin–kallikrein system, leading on to the
development of hypertension (Figure 2) [126]. ACE-I inhibitors have therefore become one of the most
commonly studied targets, and with global annual sales exceeding US $6 billion, ACE-I inhibitory drugs
can be considered as one of the major protease inhibitor success stories [238]. Synthetic ACE-I inhibitor
drugs, such as captopril, enalapril, and alacepril, often come with several side effects, including
hypotension, dry cough, and impaired renal function [19]. Function foods with anti-hypertensive
bioactivities have therefore become a popular alternative to synthetic drugs, especially for individuals
who are borderline hypertensive and do not warrant the prescription of pharmaceutical drugs [239].
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Figure 2. Schematic representation of the renin–angiotensin–aldosterone system (RAAS) and the
hypertensive effect of angiotensin-I-converting enzyme (ACE-I). Angiotensinogen is converted to the
decapeptide angiotensin-I by renin. ACE-I cleaves the C-terminal dipeptide His-Leu of angiotensin-I
to form angiotensin-II. Binding of angiotensin-II to its receptor (AT1) stimulates the secretion
of inositol 1,4,5-triphosphate (IP3) and aldosterone, which induce arteriolar vasoconstriction and
increased intravascular fluid volume, respectively, resulting in increased blood pressure. Within
the kallikrein–kinin system, kallikrein converts kininogen to bradykinin, which induces arteriolar
vasodilation by prostaglandin secretion and binding of bradykinin with its receptor, resulting in
decreased blood pressure. However, the hypotensive effect of bradykinin is largely dependent on the
rate of degradation by ACE-I, which hydrolyzes bradykinin to form inactive metabolites.
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ACE-I-inhibitory peptides have been isolated from a variety of seaweed and microalgae
sources [132]. Four tetrapeptides were identified from peptic digests of U. pinnatifida which displayed
in vitro ACE-I inhibitory and in vivo anti-hypertensive bioactivity in spontaneously hypertensive rats
(SHRs) (Table 2) [201]. Suetsuna and colleagues also identified several dipeptides from U. pinnatifida
using hot water extraction [202]. Both single administration and repeated dose administration of four
of the dipeptides significantly reduced blood pressure in SHRs. For example, a single administration
of 50 mg/kg body weight Tyr-His, Phe-Tyr, and Ile-Tyr lowered systolic blood pressure (SBP) by 50,
46, and 33 mm Hg, respectively, after 3 h [202]. The dipeptide Lys-Tyr took slightly longer to have
the greatest effect, with a reduction in SBP of 45 mm Hg observed after 6 h. Similarly, one week of
continuous oral administration of 10 mg/kg body weight/day Tyr-His, Lys-Tyr, Phe-Tyr, and Ile-Tyr
reduced SBP by 34, 26, 34 and 25 mm Hg, respectively [202]. Similarly, Sato and colleagues (2002)
also identified ACE-I inhibitory peptides from U. pinnatifida which displayed in vitro and in vivo
bioactivity [203].
Dipeptides were isolated from wakame Protease S “Amano” hydrolysates by three-step
high-performance liquid chromatography. The peptides showed strong ACE-I inhibitory potency and
four of the dipeptides (Val-Tyr, Ile-Tyr, Phe-Tyr, and Ile-Trp) were reported to significantly reduce
blood pressure in SHRs comparable to that of the positive control (captopril) when administered
at a dose of 1 mg/kg body weight (Table 2) [203]. Cha and colleagues (2006) reported promising
peptides derived from digestion of 70 ◦C aqueous extracts of E. cava using five proteases from Novo Co.
(Novozyme Nordisk, Bagsvaerd, Denmark), including alcalase, flavourzyme, kojizyme, neutrase,
and protamex [204]. ACE-I inhibitory peptides have also been isolated from P. columbina, P. palmata,
Bangia fusco-purpurea, P. yezoensis, and H. fusiformis (Table 2) [205–207,235,240].
In addition to seaweed, ACE-I inhibitory bioactive peptides have also been isolated from a
number of microalgae species. Suetsuna and Chen (2001) identified several peptides from C. vulgaris
and A. platensis which displayed promising ACE-I inhibitory and anti-hypertensive activity in SHRs
(Table 2) [208]. Nannochloropsis oculata has been shown to be a promising source of commercially
exploitable biodiesel due to its high lipid content (up to 28.7% dw) [209]. In order to maximise its
potential, while minimising waste disposal costs, biodiesel by-products were analysed for ACE-I
inhibitory peptides. The commercial enzymes Alcalase, Neutrase, Flavourzyme, Pancreatic Trypsin
Novo (PTN), and Protamex were used to generate hydrolysates, of which the Alcalase-generated
peptide Leu-Val-Thr-Val-Met was identified as the most potent [209]. In a similar study, N. oculata
was also digested with a variety of proteases, including pepsin, trypsin, α-chymotrypsin, papain,
Alcalase, and Neutrase for the generation of ACE-I inhibitory hydrolysates [210]. The pepsin
hydrolysates exhibited the highest ACE-I inhibitory bioactivity, of which two peptide sequences
(Gly-Met-Asn-Asn-Leu-Thr-Pro and Leu-Glu-Gln) in particular were identified as having the greatest
activity (Table 2). Hydrolysis of C. ellipsoidea using the proteases Protamax, Kojizyme, Neutrase,
Flavourzyme, Alcalase, trypsin, α-chemotrypsin, pepsin, and papain generated several ACE-I
inhibitory peptides, of which Val-Glu-Gly-Tyr was shown to be the most potent in vitro ACE-I inhibitor
and in vivo anti-hypertensive with SHRs (Table 2) [211].
An anti-hypertensive peptide (Ile-Arg-Leu-Ile-Ile-Val-Leu-Met-Pro-Ile-Leu-Met-Ala) has also been
isolated from P. palmata, which was reported to inhibit renin at concentrations similar to that that of the
positive control [241]. Renin catalyzes the initial rate-limiting step within the RAAS, and is therefore
an important target for the treatment of high blood pressure (Figure 2) [242].
5. Challenges
5.1. Access Rights
At present, all seaweed species are harvested by hand in Ireland. This includes the most
economically valuable species brown seaweed Ascophyllum nodosum and the red calcified coralline
seaweeds Phymatolithon purpureum and Lithothamnion corallioides (commonly called maërl) [243].
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The legislation for harvesting seaweed in Ireland is based on the Foreshore Acts 1933–1998, which
states that the Department of Communications Marine and Natural Resources is empowered to grant
licences for seaweed harvesting on the seabed out to 12 nautical miles [244]. There are currently no
restrictions on harvesting quantities in Ireland, nor are there any restrictions on harvesting times. The
only exception to this is for maërl due to its extremely slow growth rate (0.6–1.5 mm per annum) [245].
However, the future implementation of mechanical harvesting methods will likely require a review of
existing legislation to ensure appropriate access rights and sustainable harvesting yields are maintained.
Mechanical harvesting of Laminaria spp. is already present in various European countries, such as
France and Norway, providing a valuable resource for making any such revisions [243].
5.2. Variability
An additional challenge, which is particularly relevant in the production of bioactive peptides, are
the high levels of variability in algal proteins. The protein content can vary by season, temperature, and
location in which the seaweed is harvested [46]. The relative composition of particular proteins within
the plant can also differ, changing the concentrations of amino acids and therefore altering the yield of
desired peptides as a consequence [246]. For example, annual monitoring of P. palmata harvested on
the French Atlantic coast showed that protein levels were highest in the winter and spring months,
varying from 9 to 25%, and peaking in May [247]. Similarly, Gracilaria cervicornis and S. vulgare varied
by season, with protein levels negatively correlating with temperature and salinity [248]. Different
harvest locations of U. pinnatifida in New Zealand also significantly affected the protein content and
amino acid composition [249].
5.3. Scalability
The scalability of protein extraction from algae is a further obstacle that needs to be overcome
before seaweed and microalgae become a viable source. Algal protein extraction is still very much in
its infancy, meaning that many of the methods that have been developed are still at small scale [132].
PEF and ultrasound have been suggested as being suitable for large scale algal protein extraction [250].
Membrane technologies may also be scalable for commercial applications, with ultrafiltration reported
as being suitable for R-phycoerythrin extraction from the seaweed G. turuturu at the industrial
scale [109].
5.4. Digestibility
One of the most important challenges for extracting proteins from algae is the high levels of cell
wall anionic polysaccharides which can become bound to the proteins and create viscous medium,
further increasing the difficulty of protein extraction [46]. The morphology of different seaweed species
has been suggested to be an important factor in determining protein yield, with tougher thallus forms
reported to require increased processing [68]. Several brown algae species (Eisena bicyclis, H. fusiformis,
U. pinnatifida) were reported to have reduced in vitro digestibility (51.8%–57.1%) compared to red
algae P. palmata and P. tenera (70.2% and 87.3%, respectively), which was suggested to have been due
to increased levels of dietary fibre [34]. Furthermore, the type of polysaccharide has been shown to
influence the level of protein digestion. P. palmata and G. verrucosa, both red seaweeds, were shown to
have significantly different levels of in vitro corrected nitrogen digestibility (1.9% and 16.3% after 6 h,
respectively) [251]. This was largely attributed to differences in polysaccharide fractions (pentoses and
hexoses, respectively).
Treatments to disrupt the cellulosic cell wall could help to overcome this issue to make algal
proteins and other cell components more accessible [28]. Heat treatment is one such option that can
improve food taste, texture, safety in terms of allergenicity and microbial load, and preservation, while
also increasing bioavailability and utilisation of proteins by partial denaturation and breakdown of
proteins into peptides, allowing for easier access by proteolytic enzymes [252]. An example of this
can be seen with boiling of P. palmata , resulting in a 64%–96% increase in liberated amino acids [253].
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Alternatively, fermentation can also increase protein digestibility due to the degradation of insoluble
fibres, such as xylan. This can be seen with the fermentation of P. palmata using the fungal mould
Trichoderma pseudokoningii which was found to decrease the xylan content from 53% to 19% dw [75].
Washing in distilled water has also been shown to be a simple, yet effective method for improving
in vitro digestibility by solubilising and removing mineral salts [75].
Alternatively, the method of drying seaweed has been shown to influence algal protein digestibility.
Compared to freeze-drying, oven-drying was demonstrated to significantly improve (p < 0.05,
two-way ANOVA) the protein extractability and in vitro bioaccessibility of brown seaweed species
Sargassum hemiphyllum, Sargassum henslowianum, and Sargassum patens [45]. The increased extractability
from oven-drying were suggested to have been due to the decomposition of phenolic compounds at
the high temperatures, as well as increased disruption of anionic or neutral polysaccharides found
within the cell wall of the seaweed [45].
Protein digestibility can also be largely influenced by the presence of phenolic compounds
present in algae, especially phlorotannins in brown seaweeds [45]. Oxidised phenolic compounds can
react with amino acids to form insoluble complexes, which may inhibit proteolytic enzymes and thus
decrease their nutritive values [65]. The negative correlation between phenolic content and digestibility
was demonstrated by U. lactuca which was reported to have higher phenolic content (38.8 ± 0.5%)
compared to the red algae H. charoides (16.9% ± 1.0%) and H. japonica (16.3% ± 0.03%) and thus, lower
bioaccessibility (85.7% ± 1.9%, 88.7% ± 0.7%, and 88.9% ± 1.4%, respectively) [65]. This is likely to be
a greater issue in brown algae, as these are typically higher in phenolics, including catechins, flavanols,
and phlorotannins [10,67].
5.5. Food Safety
While algae can be natural accumulators of vitamins and minerals, they can also gather toxic
elements, such as heavy metals. There are therefore strict legal limits in Europe for the safe
maximum exposure of heavy metals, such as mercury, arsenic, lead, and cadmium, in foods for
human consumption. These limits are based upon the recommendations of the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) and the Panel on Contaminants in the Food Chain
of the European Food Safety Authority (CONTAM Panel), and are outlined in the legislation under
Commission Regulation (EC) No. 1881/2006 [254].
The tolerable weekly intake (TWI) of methylmercury, arsenic, lead, and cadmium are 1.6, 15, 25,
and 25 µg/kg body weight, respectively [255–258]. The CONTAM panel has reported that the current
lead TWI (15 µg/kg body weight) may no longer be appropriate due to low levels found in foodstuffs,
while arsenic TWI (1.6 µg/kg body weight) should be lowered due to cancers and adverse effects
observed at current legal limits [256,257]. Lead and mercury appear to occur in algae at levels that are
safe for human consumption [259,260]. In contrast, arsenic and cadmium have been identified in algae
at levels above the legal limits, with H. fusiformis in particular containing a high content of these toxic
heavy metals [259,260]. Microalgae do not appear to exceed legal levels of heavy metals [261].
The lack of regulation for algae as a dietary supplement is of additional concern, leading to large
variations between different batches from the same producer [262]. This has led to concerns being
raised about quality and contamination at the production and processing stages [263]. Downstream
applications for which the algal proteins are intended can play a role in determining processing
methods. For example, food grade reagents and processes may be required for proteins intended for
human consumption, whereas this may not be such an issue with proteins intended for commercial
applications or animal feed [264]. Furthermore, any reagents used for the production or extraction of
algal proteins must also be environmentally friendly with minimum impact on local ecosystems [265].
Following protein extraction, greater emphasis must additionally be placed on protein purification,
with salt removal and buffer exchange being important steps [266]. Membrane technologies, such
as ultrafiltration and nanofiltration, have already been implemented in this context within the dairy
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industry, although these technologies could also be used for other food applications, including algal
proteins [267].
5.6. Price
A critical factor that will determine the commercial viability of microalgae and seaweed is
their competitiveness compared to other sources on the market. For example, a major application
for the production of microalgae is the extraction of lipids to be converted to biofuel. However,
while they are a greener alternative for the environment, they are still not competitive compared to
fossil-based petroleum fuels [266]. Algae competitiveness could be further increased by taking a holistic
view and maximising the extraction of all available high-value components by cascading biorefinery.
Conventional methods of algal protein extraction are often quite wasteful as they typically dispose of
the algae by-products following processing [88]. Seaweed is ideally suited for cascading biorefinery
because it contains many high-value components as well as bulky low-value components that are
considered raw materials for the bio-based economy, such as xylose and glucose [268]. As several
studies have shown, the by-products of algae can still have many applications that could be of economic
value [209,215,224]. Further research is needed to develop new methods that will enable algal protein
production, extraction and processing costs to be lowered.
6. Discussions
Seaweed and microalgae are generally considered to be a promising source of nutrition, rich
in vitamins, minerals, and protein. Some species have even been reported to display protein at
concentrations greater than traditional plant and animal protein sources [28]. Within these protein
sequences, bioactive peptides have been identified with beneficial properties for human health,
including antioxidant, anticancer, anti-hypertensive, immunosuppressive, anti-atherosclerosis, and
hepatoprotective effects [198]. Algae have also been reported to contain high quality proteins in terms
of EAA content [3], as well as displaying in vitro protein digestibility that is comparable to commonly
consumed plants [67]. However, there are conflicting reports about the bioavailability of algal proteins
when examined in vivo. Several studies have demonstrated that consumption of raw, unprocessed
seaweed can result in reduced growth [43,44]. In contrast, other studies have reported opposite
findings, with seaweed proteins suggested as being a beneficial dietary supplement for improved
animal growth, meat quality, and valorisation [155,161,162]. Furthermore, microalgae have long been
used as the basal diet in the rearing of animals in aquaculture, especially molluscs [138].
One of the major reasons for reduced protein digestibility was suggested to be due to the high fibre
content that makes up the algal cell wall [46]. Algae typically contain high levels of polysaccharides,
although this can vary significantly in seaweed (4%–76% dw) and microalgae (8%–64% dw) according
to species and time of harvest [22,28]. Similarly, phenolic compounds can react with amino acids to
form insoluble compounds [65]. Great emphasis has therefore been placed on researching methods
for breaking down of the anionic cell wall in order to allow the release of the valuable intracellular
contents [13].
Conventional protein extraction methods, such as enzymatic hydrolysis and physical processes,
are laborious, time-consuming, and may require the use of solvents [13]. Novel protein extraction
methods, such as UAE, PEF, and MAE, have thus been investigated as a means of overcoming these
limitations. UAE is a cost-effective and low-solvent consumption method for extraction of high-value
compounds. UAE is already widely used at commercial scale in food processing and could therefore
also be implemented for the extraction of algal proteins [81]. PEF for the extraction of intracellular
algal components is still in its infancy, having predominantly been used for lipid extraction [93].
Nevertheless, its lack of solvent consumption or heat gives it potential for the future extraction of
algal proteins [100]. MAE has been poorly studied in algae, although the high temperature involved
would likely make it unsuitable for extraction of proteins [81]. Alternatively, membrane filtration
technologies, such as those used in the dairy industry, could also be considered a gentle method for
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protein enrichment when used in conjunction with cell disruption methods. MF has already been
demonstrated for harvesting whole microalgal cells, while UF was reported for the extraction of algal
polysaccharides [106,107]. However, there remains to be a distinct lack of studies investigating the use
of membrane technologies in the enrichment of algal proteins.
In conclusion, algae have been reported as a valuable source of nutrition. However, there are
inconclusive reports about the digestibility of algae and the bioavailability of the proteins within. More
research is needed to investigate the bioavailability of algal proteins in vivo. Cell disruption techniques
will likely play an essential role in the successful extraction and enrichment of algal protein ingredients
at a commercial scale. The most promising methods that have been used in algae to date are UAE and
PEF, both of which are non-thermal, require low solvent consumption, and have been implemented at
commercial scale for the extraction of compounds in other food processes. Alternatively, membrane
technologies are a method for isolating compounds which show great promise, but have yet to be
investigated sufficiently in algae.
Acknowledgments: Stephen Bleakley is in receipt of a Teagasc Walsh Fellowship (Grant No. 2016073). This work
forms part of the BioAlgae project funded by the Teagasc (Grant No. NFNY6889-142).
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
EAA(s) essential amino acid(s)
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